Dendritic Cells (DCs), the most potent antigen-presenting cells, play a critical role in the detection of invading pathogens, which are recognized also by multiple carbohydrate-specific receptors.
Our group has recently described the synthesis of a small library of glycomimetic DC-SIGN ligands, characterized by the presence of a β-amino acid tether and a fucosylamide anchor. [16] [17] Most of these molecules bind DC-SIGN with an affinity similar to or better than that of the Le X trisaccharide (Galβ1-4[Fucα1-3]GlcNAcβ1), one of its natural fucose-containing ligands. [4] [5] In particular, N-α-fucosyl-β-alanylamide 1a (Figure 1 ), which can be prepared in a single step from fucosyl azide, binds to DC-SIGN with almost the same affinity as Le X , that has often been used as a DC-SIGN targeting unit in the context of polyvalent constructs.
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HCl Hence, fucosylamide 1a could clearly represent an inexpensive and effective alternative to the Le x trisaccharide to build DC-SIGN targeting-devices. Indeed, some recent studies indicate that even simple monosaccharides can lead to selective nanoparticle recognition and uptake by immune system cells. [19] [20] We therefore synthesized gold nanoparticles (AuNPs) functionalized with multiple copies of 1a and measured their ability to interact with DC-SIGN on human DCs and to trigger cellular responses following interaction. AuNPs represent an accessible platform for multivalent presentation. These nanomaterials are relatively easy to synthesize and purify, and their size, shape and coating composition can be finely controlled by choosing the appropriate methodology of preparation. [21] [22] [23] [24] Moreover the globular shape of spherical gold nanoparticles allows a defined and stable 3D presentation of the binding ligand. Finally, gold nanoparticles are considered biocompatible and viable for in vivo applications. 25 Here we show that AuNPs bearing 50% of fucosylamide ligand 1a compete with gp120 on DC-SIGN expressing cells with a potency comparable to analogous particles functionalized with much more complex DC-SIGN binding oligosaccharides, such as Le X . We also show that these particles promote DC-SIGN internalization, do not induce DC maturation and do not trigger cytokine responses, as demonstrated for some other DC-SIGN ligands. 26 Thus, the AuNPs described in this manuscript can be considered as excellent DC targeting agents and carriers able to deliver antigenic cargo to DCs through DC-SIGN. They appear to lack any immune modulatory capacity, which makes them suitable for use as a basis for antigen-specific vaccination in autoimmunity or cancer, when used with appropriate adjuvants.
Results and discussion
The AuNPs were prepared by reduction of tetrachloroauric acid by NaBH 4 in the presence of a thiol (or a mixture of thiols), using Brust's method 27 as modified by Penadés (Scheme 1). 28 The required thiols were generated starting from tri-O-acetyl-α-L-fucosyl-β-alanine 1b 29 that was conjugated to commercially available polyethylene glycolic linker 2, where the disulfide bridge masks the terminal thiol groups. The divalent linker was activated as a bis N-hydroxysulfosuccinimide ester and then treated with 1b in 4:1 phosphate buffer saline (pH 7.3) : CH 3 CN. The desired bis amide 3 was recovered after purification in 30% yield. Acetyl groups removal with 4M CH 3 NH 2 in EtOH afforded the free glycosyl amido-PEG 4, which was used without further purifications. Direct conjugation of the unprotected fucosylamide 1a to the activated linker was also attempted; however it was complicated by formation of an undesired side-product, presumably the furanose form of the fucose ring. The free thiol function of 4 and/or 2 was unmasked in the presence of AuCl 4 H by NaBH 4 reduction of the disulfide bond. The resulting dark suspension of gold nanoparticles was shaken for ca. 2 h at room temperatures and the particles were purified by centrifugal filtration (Vivaspin filters, 10000 MWCO). Using this protocol, the coating composition of the AuNPs is determined by the mixture of thiols used in the reaction. In particular, 15, 30 and 50% mixtures of fucosylamide-derivatized linker 4 and unfunctionalized linker 2 were used, to afford AuNPs 5b-d, respectively. They were used to investigate the effect of ligand density on AuNP activity. Higher concentrations were not considered, assuming that further increasing the density of the sugar would not improve receptor binding. 30 Control nanoparticles AuNP 5a were also prepared, bearing no fucose ligands. All the particles synthesized were water-soluble and could be re-dissolved after lyophilization. They were characterized by high-resolution transmission electron microscopy (HR- 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 presence of IL-10 in the supernatant was determined by ELISA ( Figure 3b ). AuNPs 5 were not able to enhance LPS mediated IL-10 secretion. On the contrary, a glycopeptide dendrimer carrying Le b (Le b D3, Figure 3b ) used as positive control, induced LPS mediated IL-10 up-regulation as previously described. 11 Thus, AuNPs 5 seem to behave as pure targeting devices and be unable to induce DC maturation or to trigger some of the well-known DC-SIGN mediated signaling-cascades.
In this context, it may be worth noting that AuNPs displaying ManNAc mono-and di-saccharides 19 or galactofuranose 20 have been reported to induce significant activation of antigen presenting cells. 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 and it was directly proportional to the amount of N-fucosylamide present on the AuNPs (Figure 4b ).
DC-SIGN internalization is one of the first events occurring after carbohydrate-recognition and it is related to the ability of this lectin to present antigens to the histocompatibility complexes MHC-I and II. 33 The ability of AuNPs 5b-d to internalize DC-SIGN on DCs suggests that these nanomaterials can be explored for antigen-targeting to DCs. 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 without triggering DC maturation or the induction of IL-10. Thus they can be regarded as neutral carriers and DC-SIGN targeting devices. Their use as targeted imaging tools and antigen delivery devices will be explored in due course.
Experimental procedures
Chemistry. General: All chemicals and solvents were purchased from Sigma-Aldrich, including linker 2. They all were of reagent grade and were used without further purification. Solvents were dried by standard procedures and reactions requiring anhydrous conditions were performed under
Nitrogen atmosphere. N-(β-Alanyl)-2,3,4-tri-O-acetyl-α-L-fucopyranosyl amine 1b was prepared
according to a reported procedure. 29 Mass spectra were obtained with an ESI apparatus Bruker Esquire 3000 plus. Thin layer chromatography (TLC) was carried out with pre-coated Merck F 254 silica gel plates. Flash chromatography was carried out using the SP1 Flash Purification System by Biotage. 1 H and 13 C NMR spectra were recorded at 300 K on Bruker AVANCE 400 MHz.
Chemical shifts δ are expressed in ppm relative to internal Me 4 Si as standard. .
General procedure for nanoparticles preparation
The AuNPs were prepared following a described protocol. 28 A 0.012M (3 equiv) solution of the commercially available linker 2 and of the α-fucosyl amide disulfide 4 (in different proportions) in 1:1 MeOH/H 2 O was added to a solution of tetrachloroauric acid (0.025M, 1 equiv) in water. An aqueous solution of NaBH 4 (1M, 22 equiv) was then added in four portions, with rapid shaking.
The black suspension formed was shaken for an additional 2 h at room temperature. After this time the nanoparticles were purified by centrifugal filtration (Vivaspin filters, 10000 MWCO). The solution was finally lyophilized to afford the desired AuNPs. 1 H-NMR spectra of the obtained AuNPs were recorded. The particle size distribution of the gold nanoparticles was evaluated from HRTEM micrographs by means of an automatic image analyser. The average molecular formula of the nanoparticles was calculated on the basis of the average diameter obtained by TEM. 33 were maintained in RPMI 1640 medium containing 10%
Stable K562/DC-SIGN LL/Y transfectants
Fetal Calf Serum 1000 IU/ml penicillin (BioWhittaker, USA), 1000 IU/ml streptomycin (BioWhittaker, USA), and 2 mM glutamine (BioWhittaker, USA). Transfectants were regularly selected using 1 mg/ml Geneticin (Invitrogen, USA). To check for DC-SIGN expression, cells were incubated with primary antibody (AZN-D1) followed by staining with a secondary FITC-labeled anti-mouse antibody (Zymed, USA) and analyzed by flow cytometry on a FACScan flow cytometer (BD Biosciences, USA). Cell viability was measured using 7-amino actinomycin D (Invitrogen, USA).
DC-SIGN-Fc ELISA. 31 Nunc MaxiSorp plates were coated with 50 µL AuNPs (15 µg/mL in coating buffer, 50mM Na 2 CO 3 , pH=9.7) for 2 h at room temperature. The wells were washed twice with TMS (2x200µL) and blocked with 100 µL TMS with 1% of BSA for 30 min at room temperature. After 1x200µL wash with PBS, the wells were incubated at 37°C with 50 µL DC-SIGN-Fc (3 µg/mL) in TMS with 1% of BSA for 1 h. The wells were washed four times with TMS (4x200µL) and incubated at room temperature with 50 µL of Goat-anti human HRP (0.8 µg/mL) in TMS with 1% of BSA for 30 min. After four washes with TMS (4x200µL), 100 µL of substrate solution (3,3′,5,5′-Tetramethylbenzidine, TMB, in citric/acetate buffer, pH=4, and H 2 O 2 ) were added and after 4 min at room temperature the reaction was stopped with 50 µL of H 2 SO 4 (0.8M) and the plate was read at 450 nm ELISA reader. All the experiments were performed in triplicate. 21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 Flow cytometry analysis of DC surface molecules and cytokine production. Suspensions of 100 µL immature DCs (1.10 6 cells/mL) were stimulated by addition of AuNPs (1 µg/mL) for [16] [17] [18] [19] [20] hours at 37°C in the presence of 5% CO 2 . 10 ng/mL LPS (E. coli, Sigma-Aldrich) served as a control. Cells were then collected by centrifugation, washed with 1% BSA in phosphate-buffered saline and incubated with mouse anti-human CD86 conjugated with phycoerythrin (PE, BD Pharmingen, San Diego, CA). After 30 min incubation at 4°C, cells were analyzed using a flow cytometer (FACS Calibur, BD Biosciences, USA).
IL-10 ELISA. For the detection of IL-10, culture supernatants were harvested 24 h after DC stimulation and frozen at -80°C until analysis. Cytokines were measured by ELISA using antibody pairs from eBioscience (The Netherlands) and according to manufacturer's protocols.
Internalization assay. DCs were incubated in the presence of gold nanoparticles at either 4°C or 37°C for 60 min. Cells were then washed, fixated, stained against DC-SIGN using the polyclonal antibody CSRD 36 and an AF488-labeled goat-anti-rabbit antibody, and then prepared for acquisition on the ImageStreamX (Amnis corp., Seattle) imaging flow cytometer. The following laser powers were used: 488 nm at 20 mW and 785 nm at 4.5 mW. Brightfield illumination was set at 800 mW before the acquisition of each sample. Brightfield images were collected in channels 1 and 9.
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